Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015.

Mycoplasma pneumoniae infection can cause pneumonia, particularly in children. Global increase in macrolide-resistant M. pneumoniae is of concern due to limited therapeutic options. We describe the detection of macrolide resistance-conferring mutations in 9.3% of 43 clinical specimens where M. pneumoniae was detected in England and Wales from September 2014‒September 2015. This study aims to impact by highlighting the presence of macrolide resistance in M. pneumoniae positive patients, promoting increased clinical vigilance.

[1]  Maureen H Diaz,et al.  Outbreak of Mycoplasma pneumoniae–Associated Stevens-Johnson Syndrome , 2015, Pediatrics.

[2]  F. Zhou,et al.  A case of lethal hemolytic anemia associated with severe pneumonia caused by Mycoplasma pneumoniae. , 2014, Chinese medical journal.

[3]  S. Cunningham,et al.  Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK. , 2013, Journal of medical microbiology.

[4]  W. Hop,et al.  Carriage of Mycoplasma pneumoniae in the Upper Respiratory Tract of Symptomatic and Asymptomatic Children: An Observational Study , 2013, PLoS medicine.

[5]  S. Esposito,et al.  Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. , 2013, The Journal of antimicrobial chemotherapy.

[6]  Jiang Wu,et al.  Surveillance of Macrolide-Resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012 , 2012, Antimicrobial Agents and Chemotherapy.

[7]  C. Bébéar.  Editorial commentary: infections due to macrolide-resistant Mycoplasma pneumoniae: now what? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  D. Coulombier,et al.  Surveillance status and recent data for Mycoplasma pneumoniae infections in the European Union and European Economic Area, January 2012. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[9]  D. Mant,et al.  Mycoplasma pneumoniae and Respiratory Virus Infections in Children With Persistent Cough in England: A Retrospective Analysis , 2011, The Pediatric infectious disease journal.

[10]  John S. Bradley,et al.  The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  A. Harnden,et al.  British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011 , 2011, Thorax.

[12]  S. Esposito,et al.  Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia , 2011, European Respiratory Journal.

[13]  S. Pereyre,et al.  Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. , 2011, Future microbiology.

[14]  D. Fleming,et al.  Mycoplasma pneumoniae infection in primary care investigated by real-time PCR in England and Wales , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[15]  M. Narita.  Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia , 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[16]  W. Lim,et al.  BTS guidelines for the management of community acquired pneumonia in adults: update 2009 , 2009, Thorax.

[17]  J. Hagood,et al.  Emerging Macrolide Resistance in Mycoplasma pneumoniae in Children: Detection and Characterization of Resistant Isolates , 2009, The Pediatric infectious disease journal.

[18]  S. Pereyre,et al.  Mechanisms of drug resistance in Mycoplasma pneumoniae. , 2005, Current drug targets. Infectious disorders.

[19]  Ari Bitnun,et al.  Mycoplasma pneumoniae ecephalitis. , 2003, Seminars in pediatric infectious diseases.

[20]  N. Ghanayem,et al.  Mycoplasma hominis and Ureaplasma species brain abscess in a neonate. , 2002, The Pediatric infectious disease journal.

[21]  Michael J Fine,et al.  Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.